Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
12 2022
Historique:
received: 03 01 2022
revised: 27 04 2022
pubmed: 18 6 2022
medline: 6 12 2022
entrez: 17 6 2022
Statut: ppublish

Résumé

Total metabolic tumor volume (TMTV) and tumor dissemination (Dmax) calculated from baseline

Identifiants

pubmed: 35710733
pii: jnumed.121.263501
doi: 10.2967/jnumed.121.263501
pmc: PMC9730929
doi:

Substances chimiques

Biomarkers 0
Fluorodeoxyglucose F18 0Z5B2CJX4D

Banques de données

ClinicalTrials.gov
['NCT01122472', 'NCT00498043']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1925-1932

Informations de copyright

© 2022 by the Society of Nuclear Medicine and Molecular Imaging.

Références

J Nucl Med. 2020 Jan;61(1):40-45
pubmed: 31201248
Clin Cancer Res. 2016 Aug 1;22(15):3801-9
pubmed: 26936916
Radiology. 2020 Feb;294(2):445-452
pubmed: 31821122
Ann Oncol. 2021 Mar;32(3):404-411
pubmed: 33278600
Blood. 2017 Sep 14;130(11):1315-1326
pubmed: 28701367
Cancer Res. 2018 Aug 15;78(16):4786-4789
pubmed: 29959149
Eur J Nucl Med Mol Imaging. 2017 Aug;44(Suppl 1):97-110
pubmed: 28411336
Blood. 2020 Apr 16;135(16):1396-1405
pubmed: 31978225
J Nucl Med. 2022 Apr;63(4):500-510
pubmed: 34740952
Eur J Cancer. 2020 Jan;124:25-36
pubmed: 31710995
J Clin Oncol. 2007 Feb 10;25(5):579-86
pubmed: 17242396
Radiol Artif Intell. 2020 Mar 25;2(2):e200029
pubmed: 33937821
Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1209-19
pubmed: 26902371
Eur J Nucl Med Mol Imaging. 2021 May;48(5):1362-1370
pubmed: 33097974
IEEE Trans Med Imaging. 2021 Jun;40(6):1542-1554
pubmed: 33606627
Cancers (Basel). 2021 Aug 08;13(16):
pubmed: 34439152
Biometrics. 2000 Jun;56(2):337-44
pubmed: 10877287
J Nucl Med. 2021 Jan;62(1):30-36
pubmed: 32532925

Auteurs

Kibrom B Girum (KB)

LITO Laboratory, U1288 Inserm, Institut Curie, University Paris-Saclay, Orsay, France.

Louis Rebaud (L)

LITO Laboratory, U1288 Inserm, Institut Curie, University Paris-Saclay, Orsay, France.
Research and Clinical Collaborations, Siemens Medical Solutions, Knoxville, Tennessee.

Anne-Ségolène Cottereau (AS)

LITO Laboratory, U1288 Inserm, Institut Curie, University Paris-Saclay, Orsay, France.
Department of Nuclear Medicine, Cochin Hospital, AP-HP, Paris Descartes University, Paris, France.

Michel Meignan (M)

Lysa Imaging, Henri Mondor University Hospital, AP-HP, University Paris East, Créteil, France.

Jérôme Clerc (J)

Department of Nuclear Medicine, Cochin Hospital, AP-HP, Paris Descartes University, Paris, France.

Laetitia Vercellino (L)

Department of Nuclear Medicine, Saint-Louis Hospital, AP-HP, Paris, France.

Olivier Casasnovas (O)

Department of Hematology, University Hospital of Dijon, Dijon, France.

Franck Morschhauser (F)

Department of Hematology, Claude Huriez Hospital, University Lille, EA 7365, Research Group on Injectable Forms and Associated Technologies, Lille, France; and.

Catherine Thieblemont (C)

Department of Hematology, Saint Louis Hospital, AP-HP, Paris, France.

Irène Buvat (I)

LITO Laboratory, U1288 Inserm, Institut Curie, University Paris-Saclay, Orsay, France; irene.buvat@u-psud.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH